FLT3 and acute myeloid leukemia: These authors concluded that the patients with FLT3-D835 mutations with intermediate cytogenetics had similar overall survival as wild-type FLT3 patients, and adult AML patients with FLT3-D835 mutations exhibited better outcomes than those with FLT3-ITD.